Pharma News, Research & Solutions CSR News

CRB Celebrates Henrietta Lacks

Multimedia with summary

Sometimes people make incredible contributions to science and society, but aren't recognized in their lifetime. Henrietta Lacks may be the biggest example of all. 

Suffering from cervical cancer, a biopsy was analyzed and found to host the only known cells that could replicate in a lab.

Since then, her special cells have become the foundation of a wide range of important therapeutic and medical research, including how COVID-19 spreads and behaves within human cells.

Henrietta Lacks: Mother of Modern Science

Rockwell Automation Endorses “This Is Our Shot” Campaign to Encourage COVID-19 Vaccinations in Manufacturing


Rockwell Automation today announced support for the National Association of Manufacturers' Vaccine Acceptance Campaign, “This Is Our Shot.” Last month, the campaign launched a public service announcement and website to educate and encourage manufacturing team members, their families, and communities to consider getting a COVID-19 vaccine when available.

Takeda Named a Global Top Employer for 4th Consecutive Year

Multimedia with summary

Takeda has been named a Global Top Employer for 4th consecutive year! We are especially proud of this recognition because, in 2020, everything changed. Except our patients’ need for innovative treatments and therapies. Except your dedication to your work and our purpose. And except our commitment to your career – as recognized by this award. We look forward to building on this achievement and sharing positive work experiences with you throughout 2021. 

Alkermes Shares Tips for Preventing Cancer and Spreading Awareness

Multimedia with summary

Though National Cancer Prevention Month has come to an end, Alkermes will not stop working to uncover potential new cancer immunotherapies. Share these tips that may help reduce the risk of cancer and help spread awareness.

Rare Answers™: A System to Improve Patient Outcomes


At Alexion, Corporate Social Responsibility (CSR) is an inherent part of everything we do and supports our mission to transform the lives of people affected by rare diseases and devastating conditions. In addition to developing and delivering life-changing medicines, this mission drives us to seek opportunities to advance innovative solutions to system-wide challenges faced by rare disease patients, such as the “diagnostic odyssey.”

Health Equity at Alexion


As a leader in rare disease, it is our responsibility to lead critical conversations with stakeholders and other members of the rare disease community. Health equity is one of those conversations.

Comcast NBCUniversal Wants to Help You 'Plan Your Vaccine,' Launches Nationwide Awareness Campaign and Website

Press Release

NEW YORK, February 12, 2021 /3BL Media/ - Today, Comcast NBCUniversal announced the launch of Plan Your Vaccine, a nationwide awareness campaign, website and interactive tool that will provide the latest news and information about when and where people can receive the COVID-19 vaccine.

Ukko Secures USD 40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities

Top industry leaders and venture firms unite behind Ukko’s efforts to eliminate the world's most prevalent food allergies and sensitivities, including peanuts and gluten
Press Release

Palo Alto /Tel Aviv / Leverkusen, January 27, 2021 /3BL Media/ – Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced USD 40 million in new Series B funding. Ukko harnesses artificial intelligence (AI) and protein engineering to develop healthier food and therapies for food allergies. The new funding will allow Ukko to enter clinical trials with its investigational therapeutic for peanut allergies. It will also accelerate development of Ukko’s gluten that is designed for people with celiac and other gluten sensitivities.

Children's Mental Health in the Time of COVID


The pandemic has exacerbated depression and anxiety, especially among children. A new Child Mind Institute survey supported by Morgan Stanley shows the depth and breadth of the problem.


The pandemic has exacerbated depression and anxiety, especially among children. A new Child Mind Institute survey supported by Morgan Stanley shows the depth and breadth of the problem.

Multimodal Manufacturing—Avoid Challenges in the ATMP Marketplace

by Noel Maestre, PE, LEED AP SlateXpace Director, and Peter Walters, Director of ATMPs

Facing pressure in the ATMP marketplace? Multimodal manufacturing is your solution for that.

Pharmaceutical developers have always been history-makers. In the 18th and 19th centuries, they gave us the world’s first vaccines. In the 1980s, they ushered in the golden age of recombinant therapeutic proteins. Today, they’ve brought us to the doorstep of advanced therapy medicinal product (ATMP) manufacturing, which is an idea that could transform how we approach the complex health needs of a global population.


Subscribe to Pharma News, Research & Solutions